株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ニュートリゲノミクスの世界市場:肥満、心血管疾患、がん研究 (2019年~2025年)

Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 786019
出版日 ページ情報 英文 80 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
ニュートリゲノミクスの世界市場:肥満、心血管疾患、がん研究 (2019年~2025年) Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025
出版日: 2019年01月31日 ページ情報: 英文 80 Pages
概要

世界のニュートリゲノミクス市場は、2025年までに8億5086万米ドルに達すると見られています。市場は、2019年~2025年のCAGR (複合年間成長率) で、16.48%の成長が予測されています。

当レポートでは、世界のニュートリゲノミクス市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 ニュートリゲノミクス市場の変数・動向・範囲

  • 市場区分・範囲
  • 普及率、成長見通しマッピング
  • SWOT分析:要因別
  • ファイブフォース分析

第4章 ニュートリゲノミクス市場:適応別の推計・動向分析

  • 動向分析
  • 肥満
  • 心血管疾患
  • がん研究

第5章 ニュートリゲノミクス市場:地域別の推計・動向分析

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 戦略的枠組み
  • 市場参入企業の分類
    • Royal DSM
    • BASF
    • Danone
    • GeneSmart
    • Unilever
    • Genova Diagnostics
    • Nutrigenomix, Inc.
    • Metagenics
    • Cell Logic
    • WellGen
図表

List of Tables

  • TABLE 1 North America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 2 U.S. Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 3 Canada Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 4 Europe Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 5 Germany Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 6 U.K Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 7 Asia Pacific Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 8 China Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 9 Japan Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 10 Latin America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 11 Brazil Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 12 Middle East and Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
  • TABLE 13 South Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restrain relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Nutrigenomics market application scope outlook: Key takeaways
  • FIG. 16 Nutrigenomics market: application scope market: movement analysis
  • FIG. 17 Global Obesity discovery market, 2014 - 2025 (USD Million)
  • FIG. 18 Global Cardiovascular Diseases, 2014 - 2025 (USD Million)
  • FIG. 19 Global Cancer research market, 2014 - 2025 (USD Million)
  • FIG. 20 Regional market place: Key takeaways
  • FIG. 21 Regional outlook, 2017 & 2025
  • FIG. 22 Strategy framework
  • FIG. 23 Participant categorization
目次
Product Code: GVR-2-68038-791-9

The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.

Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2017 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.

Further key findings from the study suggest:

The global nutrigenomics demand exceeded USD 250 million in 2017 and is expected to expand at a CAGR of 16.48% over the forecast period

Obesity application segment led the market in 2017 and is estimated to account for a 38% of the industry share by 2025

North America accounted for the largest market share in 2017 and is estimated to maintain its dominance over the years to come

The Asia Pacific market is projected to witness substantial growth over the next decade owing to increasing cases of obesity and CVD-related deaths

Key participants in the global nutrigenomics market include Koninklijke DSM N.V. (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; and Cell Logic

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Nutrigenomics Market Variables, Trends& Scope

  • 3.1 Market segmentation& scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing prevalence of obesity
      • 3.1.1.2 Increasing popularity for personalized diet
      • 3.1.1.3 Intense research for cancer prevention and cure
    • 3.1.2 Market Restrain Analysis
      • 3.1.2.1 Lack of regulatory approvals
      • 3.1.2.2 Lack of proven results for nutrigenomics study support
  • 3.2 Penetration & growth prospect mapping
  • 3.3 Nutrigenomics - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Nutrigenomics: Application Scope Estimates & Trend Analysis

  • 4.1 Nutrigenomics market: application scope movement analysis
  • 4.2 Obesity
    • 4.2.1 Obesity Discovery market, 2014 - 2025 (USD Million)
  • 4.3 Cardiovascular Diseases
    • 4.3.1 Cardiovascular Diseases, 2014 - 2025 (USD Million)
  • 4.4 Cancer research
    • 4.4.1 Cancer research market, 2014 - 2025 (USD Million)

Chapter 5 Nutrigenomics: Regional Estimates & Trend Analysis, by Technique, Application, Indication Scope

  • 5.1 Nutrigenomics market share by region, 2016 & 2025
  • 5.2 North America
    • 5.2.1 North America Nutrigenomics market, 2014-2025, (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. Nutrigenomics market, 2014-2025, (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada Nutrigenomics market, 2014-2025, (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Nutrigenomics market, 2014-2025, (USD Million)
    • 5.3.2 Germany
      • 5.3.2.1 Germany Nutrigenomics market, 2014-2025, (USD Million)
    • 5.3.3 U.K.
      • 5.3.3.1 U.K. Nutrigenomics market, 2014-2025, (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Nutrigenomics market, 2014-2025, (USD Million)
    • 5.4.2 China
      • 5.4.2.1 China Nutrigenomics market, 2014-2025, (USD Million)
    • 5.4.3 Japan
      • 5.4.3.1 Japan Nutrigenomics market, 2014-2025, (USD Million)
  • 5.5 Latin America
    • 5.5.1 Latin America Nutrigenomics market, 2014-2025, (USD Million)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil Nutrigenomics market, 2014-2025, (USD Million)
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Nutrigenomics market, 2014-2025, (USD Million)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa Nutrigenomics market, 2014-2025, (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy framework
  • 6.2 Market participation categorization
    • 6.2.1 Royal DSM
      • 6.2.1.1 Company overview
      • 6.2.1.2 Financial performance
      • 6.2.1.3 Technique benchmarking
      • 6.2.1.4 Strategic initiatives
    • 6.2.2 BASF
      • 6.2.2.1 Company overview
      • 6.2.2.2 Financial performance
      • 6.2.2.3 Technique benchmarking
      • 6.2.2.4 Strategic initiatives
    • 6.2.3 Danone
      • 6.2.3.1 Company overview
      • 6.2.3.2 Financial performance
      • 6.2.3.3 Technique benchmarking
      • 6.2.3.4 Strategic initiatives
    • 6.2.4 GeneSmart
      • 6.2.4.1 overview
      • 6.2.4.2 Financial performance
      • 6.2.4.3 Technique benchmarking
      • 6.2.4.4 Strategic initiatives
    • 6.2.5 Unilever
      • 6.2.5.1 overview
      • 6.2.5.2 Financial performance
      • 6.2.5.3 Technique benchmarking
      • 6.2.5.4 Strategic initiatives
    • 6.2.6 Genova Diagnostics
      • 6.2.6.1 Company overview
      • 6.2.6.2 Financial performance
      • 6.2.6.3 Technique benchmarking
      • 6.2.6.4 Strategic initiatives
    • 6.2.7 Nutrigenomix, Inc,
      • 6.2.7.1 Company overview
      • 6.2.7.2 Financial performance
      • 6.2.7.3 Technique benchmarking
      • 6.2.7.4 Strategic initiatives
    • 6.2.8 Metagenics
      • 6.2.8.1 Company overview
      • 6.2.8.2 Financial performance
      • 6.2.8.3 Technique benchmarking
      • 6.2.8.4 Strategic initiatives
    • 6.2.9 Cell Logic
      • 6.2.9.1 Company overview
      • 6.2.9.2 Financial performance
      • 6.2.9.3 Technique benchmarking
      • 6.2.9.4 Strategic initiatives
    • 6.2.10 WellGen
      • 6.2.10.1 Company overview
      • 6.2.10.2 Financial performance
      • 6.2.10.3 Technique benchmarking
      • 6.2.10.4 Strategic initiatives
Back to Top